SmartLabs
PrivateLast Round
Series C
Jan 18, 2024
Total Funding Raised
$334M
Company Overview
SmartLabs operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series C round in January 2024.
SmartLabs (Contract Research Organization) is a biotechnology company that builds and operates full-service laboratory spaces to enhance the speed of scientific discovery and increase the availability of effective therapeutics in the market.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Facility Management, Co-working Spaces
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SmartLabs Comparables
Compare SmartLabs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Labshares | 79% | |
| Cambridge Innovation Center | 78% | |
| BioLabs | 78% |
For institutional investors. Book with your work email.
SmartLabs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 18, 2024 | ||||
| Series B | Sep 20, 2021 | ||||
| Series A | Mar 2, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SmartLabs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Breed's Hill Capital | Series B, Series A |
| Ropes & Gray | Series B |
| Conversion Venture Capital | Series B, Series C, Series A |
| ArrowMark Partners | Series A, Series B, Series C |
| Winslow Capital | Series B, Series C |
| Onex Falcon | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2025
Announced partnership with Iwg Plc at the 2025 BIO International Convention.
- Jun 17, 2025
Partnered with Iwg Plc to integrate lab solutions into flexible workspaces.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- closes_offices_inSep 21, 2026
In 2024, SmartLabs closes its two Bay Area locations as part of a pullback from the West Coast.
- has_issues_withSep 21, 2026
In Sep '25, BioMed Realty sues SmartLabs for "repeatedly" failing to pay rent at its 21 Erie St. location in Massachusetts.
For institutional investors. Book with your work email.
SmartLabs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SmartLabs's valuation, stock price, and market status.
Is SmartLabs a public or private company?
SmartLabs is a private company.
What is the current stock price of SmartLabs?
SmartLabs is a private company, so its shares have no public market price. Caplight tracks SmartLabs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SmartLabs worth (valuation)?
Valuation information for SmartLabs is not publicly available.
Can I buy SmartLabs stock?
SmartLabs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SmartLabs's last funding round?
SmartLabs's most recent funding round was Series C on January 18, 2024.
Who are the main investors in SmartLabs?
Key investors in SmartLabs include Breed's Hill Capital, Ropes & Gray, Conversion Venture Capital, ArrowMark Partners, Winslow Capital.
Will SmartLabs IPO soon?
No public IPO plans have been announced for SmartLabs.
How can I track SmartLabs secondary market activity?
Caplight tracks bids, offers, and trades in SmartLabs's shares on secondary markets.